title: Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.
abstract: OBJECTIVE
  To determine the association between use of lipid lowering drugs (statin or fibrate) in older people with no known history of vascular events and long term risk of coronary heart disease and stroke
  
  
  METHODS
  Ongoing prospective population based cohort study recruited in 1999-2000, with five face-to-face examinations.
  
  
  METHODS
  Random sample of community dwelling population aged 65 years and over, living in three French cities (Bordeaux, Dijon, Montpellier).
  
  
  METHODS
  7484 men and women (63%) with mean age 73.9 years and no known history of vascular events at entry. Mean follow-up was 9.1 years.
  
  
  METHODS
  Adjusted hazard ratios of coronary heart disease and stroke in baseline lipid lowering drug users compared with non-users, calculated using multivariable Cox proportional hazard models adjusted for numerous potential confounding factors. Hazard ratios were estimated for use of any lipid lowering drug and for statin and fibrate separately.
  
  
  RESULTS
  Lipid lowering drug users were at decreased risk of stroke compared with non-users (hazard ratio 0.66, 95% confidence interval 0.49 to 0.90); hazard ratios for stroke were similar for statin (0.68, 0.45 to 1.01) and fibrate (0.66, 0.44 to 0.98). No association was found between lipid lowering drug use and coronary heart disease (hazard ratio 1.12, 0.90 to 1.40). Analyses stratified by age, sex, body mass index, hypertension, systolic blood pressure, triglyceride concentrations, and propensity score did not show any effect modification by these variables, either for stroke or for coronary heart disease.
  
  
  CONCLUSIONS
  In a population based cohort of older people with no history of vascular events, use of statins or fibrates was associated with a 30% decrease in the incidence of stroke.
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France.
authors.forename: Annick
authors.initials: A
authors.lastname: Alpérovitch
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France.
authors.forename: Tobias
authors.initials: T
authors.lastname: Kurth
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Bertrand
authors.affiliation: INSERM, U1061, Montpellier, France Université de Montpellier I, Montpellier, France.
authors.forename: Marie-Laure
authors.initials: ML
authors.lastname: Ancelin
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Helmer
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Debette
authors.affiliation: INSERM, U897-Epidemiology and Biostatistics, Bordeaux, France Université de Bordeaux, Bordeaux, France christophe.tzourio@u-bordeaux.fr.
authors.forename: Christophe
authors.initials: C
authors.lastname: Tzourio
mesh_terms: D000368:Aged; D015331:Cohort Studies; D005260:Female; D005602:France / Q000453:epidemiology; D006299:Health Services for the Aged; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology* / Q000517:prevention & control; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents